Showing results (131-140 of 180) with videos related to
Sort By:
Pageof 18
Alimentary Pharmacology & Therapeutics|February 18, 2022
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current dataYoung-Suk Lim, Wai-Kay Seto, Masayuki Kurosaki, et al.European Radiology|November 22, 2011
Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancerM J Gollub, D H Gultekin, O Akin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2009
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patientsEdwin Dejesus, Benjamin Young, Javier O Morales-Ramirez, et al.Alimentary Pharmacology & Therapeutics|June 26, 2020
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort studyPietro Lampertico, Thomas Berg, Maria Buti, et al.The Journal of Trauma|July 13, 2010
Feasibility of negative pressure wound therapy during intercontinental aeromedical evacuation of combat casualtiesRaymond Fang, Warren C Dorlac, Stephen F Flaherty, et al.Digestive Diseases and Sciences|September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis BNaoky C Tsai, Patrick Marcellin, Maria Buti, et al.Digestive Diseases and Sciences|December 24, 2014
Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infectionMaria Buti, Naoky Tsai, Joerg Petersen, et al.Hepatology Communications|January 8, 2020
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis BAnna S Lok, Fabien Zoulim, Geoffrey Dusheiko, et al.Journal of Clinical Gastroenterology|February 25, 2010
Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levelsKe-Qin Hu, Eugene R Schiff, Kris V Kowdley, et al.Journal of Hepatology|December 3, 2014
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infectionKosh Agarwal, Scott K Fung, Tuan T Nguyen, et al.Pageof 18